Background Sulfonylureas are common second-line options for management of type 2
diabetes; however, they are associated with a higher risk of cardiovascular events compared …

Background: Glycaemic control is suboptimal in a large proportion of people with type 2
diabetes who are consequently at an increased and avoidable risk of potentially severe …

Background: Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …

Guidelines increasingly highlight the importance of multifactorial management in type 2
diabetes, in contrast to the more traditional focus on glycemic control. Semaglutide, a …

Patients with diabetes often face serious complications due to limited self-management
skills, the inability to adhere to care regimens, and psychosocial factors. Although regular …

The proximal tubule's sodium–glucose linked transporter-2 (SGLT2) accounts for the vast
majority of glucose reabsorption by the kidney. Its selective inhibition, accordingly, leads to …

OBJECTIVE To examine the safety and cardiovascular (CV) effects of saxagliptin in the
predefined elderly (≥ 65 years) and very elderly (≥ 75 years) subpopulations of the …

Background Specialised diabetes teams, specifically certified nurse and dietitian diabetes
educator teams, are being integrated part-time into primary care to provide better care and …

Background: Nephropathy is one of the most common microvascular impediments of
diabetes mellitus. In this study, we aimed to estimate the prevalence of nephropathy in …

Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-
1 receptor agonists (GLP-1RA) have shown benefits in patients with diabetes and …